Skip to content

Darunavir superior to lopinavir in 48-week study in treatment-experienced patients

Indian HIV estimate cut to 2.5 million people

TMC-125 and darunavir show strong effect in highly treatment-experienced, even without T-20

Thai programme demonstrates HIV services can be successfully delivered in prison

Brazil: Kaletra price cut agreed as generic efavirenz arrives

Infant ARV treatment study shows advantage for immediate treatment

Risk of viral rebound decreases with longer treatment, even with previous failures

Watch your HIV epidemic closely, warns World Bank scientist, or risk pointless prevention work

Different neurological problems affecting people with HIV in the era of HAART